191 related articles for article (PubMed ID: 33544565)
21. Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
Menon MP; Nicolae A; Meeker H; Raffeld M; Xi L; Jegalian AG; Miller DC; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2015 Dec; 39(12):1719-1729. PubMed ID: 26379152
[TBL] [Abstract][Full Text] [Related]
22. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
23. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
24. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
[TBL] [Abstract][Full Text] [Related]
25. Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study.
Ko YH; Karnan S; Kim KM; Park CK; Kang ES; Kim YH; Kang WK; Kim SJ; Kim WS; Lee WY; Chun HK; Seto M
Hum Pathol; 2010 Sep; 41(9):1231-7. PubMed ID: 20399483
[TBL] [Abstract][Full Text] [Related]
26. A case of enteropathy-associated T-cell lymphoma (type I) arising in stomach without refractory celiac disease.
Wang L; Liu Y; Lin XY; Yu JH; Miao Y; Qiu XS; Wang EH
Diagn Pathol; 2012 Dec; 7():172. PubMed ID: 23217032
[TBL] [Abstract][Full Text] [Related]
27. Intestinal γδ T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type.
Wilson AL; Swerdlow SH; Przybylski GK; Surti U; Choi JK; Campo E; Trucco MM; Van Oss SB; Felgar RE
Hum Pathol; 2013 Jun; 44(6):1131-45. PubMed ID: 23332928
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
29. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment.
Meijer JW; Mulder CJ; Goerres MG; Boot H; Schweizer JJ
Scand J Gastroenterol Suppl; 2004; (241):78-84. PubMed ID: 15696854
[TBL] [Abstract][Full Text] [Related]
30. Multiple cerebral lesions in a patient with refractory celiac disease: A case report.
Horvath L; Oberhuber G; Chott A; Effenberger M; Tilg H; Gunsilius E; Wolf D; Iglseder S
World J Gastroenterol; 2020 Dec; 26(47):7584-7592. PubMed ID: 33384556
[TBL] [Abstract][Full Text] [Related]
31. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
[TBL] [Abstract][Full Text] [Related]
32. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
[TBL] [Abstract][Full Text] [Related]
33. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease.
van Wanrooij RL; Müller DM; Neefjes-Borst EA; Meijer J; Koudstaal LG; Heideman DA; Bontkes HJ; von Blomberg BM; Bouma G; Mulder CJ
J Clin Immunol; 2014 Oct; 34(7):828-35. PubMed ID: 25062848
[TBL] [Abstract][Full Text] [Related]
34. Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
[TBL] [Abstract][Full Text] [Related]
35. Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma.
Hang JF; Yuan CT; Chang KC; Wang RC; Chen BJ; Hsieh PP; Huang WT; Chuang WY; Chen TW; Yeh YC; Lin SY; Hsiao CH; Chou SC; Tseng CE; Pan ST; Chang SL; Chuang SS
Am J Surg Pathol; 2022 Sep; 46(9):1207-1218. PubMed ID: 35551151
[TBL] [Abstract][Full Text] [Related]
36. [Monomorphic epitheliotropic intestinal T-cell lymphoma: a clinicopathological analysis of twelve cases].
Chen CN; Wang Z; Jiang Y; Gao H; Tao R; Li J; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):17-21. PubMed ID: 31914529
[No Abstract] [Full Text] [Related]
37. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
38. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma.
Daum S; Hummel M; Weiss D; Peters M; Wiedenmann B; Schäper F; Stein H; Riecken EO; Foss H
Digestion; 2000; 62(1):60-5. PubMed ID: 10899727
[TBL] [Abstract][Full Text] [Related]
39. An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report.
Okumura K; Ikebe M; Shimokama T; Takeshita M; Kinjo N; Sugimachi K; Higashi H
World J Gastroenterol; 2012 May; 18(19):2434-7. PubMed ID: 22654438
[TBL] [Abstract][Full Text] [Related]
40. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
